Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ezio degli Esposti"'
Autor:
Michele Meschi, Ezio Degli Esposti, Luca Degli Esposti, Francesca Spagnoli, Pasquale Gianluca Giuri, Enrico Fiaccadori, Alberto Caiazza
Publikováno v:
Italian Journal of Medicine, Vol 8, Iss 3, Pp 161-168 (2013)
Chronic kidney disease (CKD) is associated with various consequences to the cardiovascular system and metabolic profile. The classification into stages should be useful for the physician to anticipate and treat early the manifestations of this diseas
Externí odkaz:
https://doaj.org/article/fe7eca5de905452c8eac3f3ad80d33c7
Autor:
Ezio Degli Esposti, Radovan Tomic
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 13, Iss 1, Pp 15-23 (2012)
BACKGROUND: the majority of hypertensive patients do not achieve adequate blood pressure (BP) control and thus remain at risk of cardio-cerebrovascular events. Aliskiren, a novel antihypertensive drug acting as direct renin inhibitor, was authorized
Externí odkaz:
https://doaj.org/article/a491c1c18dd34b9292a41fefbd2ea3f1
Autor:
Luca Degli Esposti, Diego Sangiorgi, Marcello Arca, Giovanni B. Vigna, Stefano Buda, Ezio Degli Esposti
Publikováno v:
Monaldi Archives for Chest Disease, Vol 76, Iss 4 (2015)
The primary aim of the STAR Study (Statins Target Assessment in Real practice) was to determine the LDLcholesterol reduction and to analyse patient’s and therapeutic factors associated to LDL-cholesterol target attainment in newly treated subjects
Externí odkaz:
https://doaj.org/article/a8d90e0b36f044df9120dd865bc8d3e7
Autor:
Luca Degli Esposti, Diego Sangiorgi, Giuseppe Di Pasquale, Gian Franco Gensini, Ido Iori, Stefano Buda, Ezio Degli Esposti
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 12, Iss 2, Pp 53-59 (2011)
Oral anticoagulant therapy is essential for the treatment and prevention of many thromboembolic disorders. The aim of the present study is to evaluate the level of anticoagulation intensity in patients treated with vitamin K antagonists (VKAs) in a c
Externí odkaz:
https://doaj.org/article/02a6c29dcf3740d8ad05b31f900b89e4
Autor:
Mirko Di Martino, Alessandro Capone, Pierluigi Russo, Luca Degli Esposti, Pierluigi Ceccarelli, Stefano Buda, Ezio Degli Esposti, Luciano Caprino
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 4, Iss 1S, Pp 15-23 (2003)
In spite of findings of large-scale clinical trials which showed an overall reduction of morbidity and mortality from coronary heart disease in patients treated with 3-hydroxy-3-metylglutaryl coenzyme-A reductase inhibitors (statins), relatively litt
Externí odkaz:
https://doaj.org/article/942b343c131545b8ae03cf589a71a6a5
Autor:
Luca Degli Esposti, Alessandro Capone, Mirko Di Martino, Stefania Saragoni, Samuele Berlini, Pierluigi Russo, Ezio Degli Esposti
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 4, Iss 1S, Pp 25-34 (2003)
The aim of the paper was to perform a pharmacoepidemiological and pharmacoeconomic analysis of antihypertensive drug treatment. An administrative database kept by the Local Health Unit of Ravenna listing patient baseline characteristics, drug prescri
Externí odkaz:
https://doaj.org/article/d7e341e8b31e49a2933baccfbb8fdbe0
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 4, Iss 1S, Pp 5-13 (2003)
A new class of anti-inflammatory agents, the selective inhibitors of cyclooxygenase-2 (COXIBs), has been recently introduced into the market for the treatment of osteoarthritis and reumatoid arthritis. Randomized and controlled clinical trials showed
Externí odkaz:
https://doaj.org/article/d749e2565a504d40b137f6774a7372a8
Autor:
Luca Degli Esposti, Alessandro Capone, Ezio Degli Esposti, Giorgio Valpiani, Mirko Di Martino, Gianluca Baio, Pierluigi Russo, Stefano Buda, Alessandra Sturani, Luciano Caprino
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 3, Iss 3, Pp 161-170 (2002)
In this study, the persistence with treatment and resources allocated in antihypertensive pharmacotherapy has been evaluated. Administrative databases of the Local Health Unit of Ravenna listing patients baseline characteristics, drug prescriptions a
Externí odkaz:
https://doaj.org/article/b68e89cf97aa426abde3f7a683fdb64a
Autor:
Lorenzo Malatino, Cristina Barlassina, Giuseppe Regolisti, Emanuela Bulla, Tracy Ann Williams, Franco Veglio, Alessandra Sturani, Martina Chittani, Erika Salvi, Daniele Cusi, Andrea Semplicini, Giovanni Fresu, Eric Boerwinkle, Patrizia Bulla, Timo P. Hiltunen, Giuseppe Argiolas, Francesca Frau, Paolo Manunta, Daniele Braga, Silvia Pitzoi, Paolo Mulatero, Giuseppe A. Scioli, Maria Francesca Ortu, Kimmo Kontula, Valeria Glorioso, Chiara Lanzani, Roberta Zaninello, Francesco Fallo, Daniela Antonella Piras, Ezio Degli Esposti, Benedetta Stancanelli, Angela Sciacqua, Ferruccio Galletti, Michele Bardini, Nicola Glorioso, Giovanbattista Desideri, Chiara Troffa, Dinesh Velayutham, Giampaolo Bernini, Francesco Perticone, Claudio Ferri, Stephen T. Turner
Publikováno v:
Pharmacogenomics. 15:1643-1652
Background: Essential hypertension arises from the combined effect of genetic and environmental factors. A pharmacogenomics approach could help to identify additional molecular mechanisms involved in its pathogenesis. Aim: The aim of SOPHIA study was
Autor:
Enrico Fiaccadori, Alberto Caiazza, Francesca Spagnoli, Michele Meschi, Ezio Degli Esposti, Luca Degli Esposti, Pasquale Gianluca Giuri
Publikováno v:
Italian Journal of Medicine, Vol 8, Iss 3, Pp 161-168 (2013)
Chronic kidney disease (CKD) is associated with various consequences to the cardiovascular system and metabolic profile. The classification into stages should be useful for the physician to anticipate and treat early the manifestations of this diseas